DEUTSCHE BANK AG\
BankPosition in ARQT — Arcutis Biotherapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in ARQT
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$9,184,794
-$17,828,272 QoQ
Shares Held
389,847
-58.1% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 1.9910375095870945.ToString("F0")%
Shared 0.ToString("F0")%
None 98.00896249041291.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. ARQT ranks #41 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in ARQT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,184,794 | 389,847 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $27,013,066 | 930,202 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,116,402 | 377,528 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,151,157 | 367,415 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,964,391 | 381,355 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $5,398,375 | 387,536 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $7,440,250 | 800,027 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $17,502,831 | 1,882,025 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $18,557,514 | 1,872,605 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $4,503,943 | 1,394,410 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $161,222 | 30,362 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $254,517 | 26,707 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $399,223 | 36,293 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $372,545 | 25,172 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $347,877 | 18,204 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $376,099 | 17,649 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $292,578 | 15,191 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $351,936 | 16,969 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $384,317 | 16,087 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $492,118 | 18,033 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $480,381 | 16,605 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,261,250 | 115,935 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $287,578 | 9,815 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $142,883 | 4,725 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $109,007 | 3,658 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||